Eslam Sadek Gaber

Eslam Sadek Gaber

Auto-generated profile, based on publicly available information

Eslam Sadek Gaber

Department of Microbiology and Immunology, National Research Centre, Dokki, Giza, Egypt

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2022 in Veterinary World
Verified
Journal Article
Open access
EIEman Shafeek Ibrahim
Eman Shafeek Ibrahim
AAAmany Ahmed Arafa
Amany Ahmed Arafa
SDSohad Mohamed Dorgam
Sohad Mohamed Dorgam
RERasha Hamdy Eid
Rasha Hamdy Eid
NANagwa Sayed Atta
Nagwa Sayed Atta
EGEslam Sadek Gaber
Eslam Sadek Gaber
Background and Aim: Mastitis is considered a significant disease of lactating animals. There are new attitudes for recognizing genes responsible for causing this disease to overcome and change the manipulation of this problem. This study aimed to isolate and identify Staphylococcus aureus strains from mastitic bovine animals and detect some specific biofilm-forming genes (icaA, icaD, and biofilm-associated protein [bap] genes clfA, fnbA, agrI, agrII, agrIII, agrIV, and cna). Materials and Methods: A total of 121 mastitic milk samples were analyzed using biochemical tests (catalase test, oxidative-fermentative test, and coagulase test) and Gram stain. Multiplex polymerase chain reaction was applied to characterize biofilm genes (icaA, icaD, bap, clfA, and fnbA) in addition to (agrI, agrII, agrIII, agrIV, and cna). Results: Among the 121 milk samples, 35 staphylococci isolates were derived with an incidence of 28.92% (35/121); among them, 19 are coagulase positive. Ninety percent of the isolates had ica genes (icaA and icaD) while bap gene was not recognized in any isolate. In addition, the incidence of fnbA, can, and clfA was 89.5% each. The prevalence of agr specific groups (agrI, agrII, agrIII, and agrIV) was 78.9%, 52.6%, 10.5%, and 15.8%, respectively. Conclusion: This study concluded that S. aureus has variant mechanisms of pathogenicity to form biofilm devoid of carrying a specific gene.

3 November 2020 in Veterinary World
Verified
Journal Article
Open access
JEJ. El-Jakee
J. El-Jakee
MEMahmoud Elhariri
Mahmoud Elhariri
MEMona A. El-Shabrawy
Mona A. El-Shabrawy
AKAfaf Khedr
Afaf Khedr
RHRiham H. Hedia
Riham H. Hedia
EREman Ragab
Eman Ragab
Background and Aim: Chlamydia psittaci is an intracellular pathogen with a broad range of hosts and endemic in nearly all bird species as well as many mammalian species. Outbreaks contribute to economic losses, especially due to infection of pet birds, poultry, and livestock. Worse, the organism has a zoonotic effect, and transmission to humans results in severe illness. Therefore, proper control measures need to be applied. We conducted a trial for the preparation and evaluation of inactivated vaccine against C. psittaci. Materials and Methods: Three C. psittaci strains (accession nos.: KP942827, KP942828, and KP942829) were grown in embryonated chicken eggs and then propagated for purification in Vero cells. The immunization experiment was experimentally performed in mice, which then were challenged with a virulent C. psittaci strain. Results: The immunization trial revealed nearly 100% protection after the challenge. The histopathological and immunofluorescence examinations of internal organs revealed that the prepared killed vaccines can effectively reduce chlamydial infection and shedding in animals with the proper level of protection. Conclusion: Our vaccine can be used to control economic and financial losses resulting from avian chlamydiosis, especially those in poultry industries. The zoonotic transmission risk highlights the need for proper control measures.